Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA staff review questions efficacy of Merck's C. difficile drug
FDA staff review questions efficacy of Merck's C. difficile drug
FDA staff review questions efficacy of Merck's C. difficile drug
Submitted by
admin
on June 7, 2016 - 4:23pm
Source:
Yahoo/Reuters
News Tags:
FDA
Merck
C. difficile
bezlotoxumab
Headline:
FDA staff review questions efficacy of Merck's C. difficile drug
Do Not Allow Advertisers to Use My Personal information
